獣医感染症診断市場

出版：MarketsandMarkets（マーケッツアンドマーケッツ）　出版年月：2022年2月

獣医感染症診断市場：テクノロジー[免疫診断、分子診断（PCR）]、動物（ペット、家畜）、エンドユーザー（参照試験所、病院、クリニック、大学）- 2026年までの世界予測

Veterinary Infectious Disease Diagnostics Market by Technology (Immunodiagnostics, Molecular Diagnostics (PCR)), Animal (Companion, Food-producing animals), End User (Reference Labs, Hospital, Clinics, Universities) – Global Forecast to 2026

レポート目次　　　　見積ご依頼・お問合せ　　　　ご購入案内

The veterinary infectious disease diagnostics market is expected to reach USD 2.6 billion by 2026 from an estimated USD 1.7 billion in 2021, at a CAGR of 9.0%. The major factors driving the growth of the veterinary infectious disease diagnostics include the growing demand for rapid tests, rising technological advancements, growth in companion animal population, rising demand for pet insurance, increasing incidence of transboundary and zoonotic diseases, rising number of veterinary practitioners in developed economies, increasing disease control & disease prevention measures, and growing animal health expenditure. With the growing consumption of animal-derived food products, there is a rising need for the effective diagnosis and treatment of diseases in animals to ensure the quality of animal-derived food products. The rising need for animal-derived food products will further increase the chances for infections, thereby driving the growth of this market in the coming years. However, high pet care costs directly impact the number of visits by pet owners to veterinary facilities, thereby restraining the growth of this market and the lack of reimbursement for veterinary procedures is another factor limiting the uptake of veterinary infectious disease diagnostics. The lack of skilled veterinarians and diagnostics infrastructure, especially in developing countries, is one of the major challenges limiting the uptake of advanced diagnostic solutions among veterinarians.

Since the initial outbreak of COVID-19, multiple countries have reported infections of SARS-CoV-2 in mammals. Due to an increase in the prevalence of COVID-19 across the globe, testing volumes on humans and animals continue to rise. This has also prompted players and reference laboratories to develop new and improved animal tests. At the height of the pandemic, many countries stipulated that only urgent or emergency procedures necessary for the veterinary healthcare of companion animals could take place. However, COVID-19 pandemic is expected to have a minimal impact on the veterinary infectious disease diagnostics market during the forecast period as after few months, number of vet visits were increased and there was no delay in routine care.

Immunodiagnostics segment occupies the largest share in the global veterinary infectious disease diagnostics market in the forecasted period
Based on technology, the global veterinary infectious disease diagnostics market is segmented into Immunodiagnostics, Molecular Diagnostics, and Other Technologies. The higher preference for this technology by veterinarians, pet owners, and livestock producers contributes to the large share of the immunodiagnostics segment. The growing demand for early & accurate diagnosis; increasing preference for in-house testing; and the increasing applications of immunodiagnostics are supporting the growth of this application segment.

The companion animal segment dominated the global veterinary infectious disease diagnostics market in 2020
Based on the animal type, the global veterinary infectious disease diagnostics market is segmented into companion animal and food-producing animals. In 2020, the companion animals segment accounted for the largest share of the global veterinary infectious disease diagnostics market. The growth in this segment is attributed to the increasing pet ownership (especially in developed countries), rising penetration of pet insurance, a growing number of veterinary practitioners globally, and increasing animal disease control and disease prevention measures.

Veterinary reference laboratories are the major end users in the veterinary infectious disease diagnostics market
Based on end users, the global veterinary infectious disease diagnostics market is segmented into veterinary reference laboratories, veterinary hospitals and clinics, point-of-care testing/in-house testing, and veterinary research institutes and universities. In 2020, veterinary reference laboratories were the major end users in the veterinary infectious disease diagnostics market. The large share of this segment can primarily be attributed to the growing number of veterinarians, the increasing number of veterinary practices, and the rising number of samples received for diagnostics in reference laboratories from small and large animal practices. Rising awareness among pet owners regarding routine and preventive care is further expected to propel market growth.

North America accounts for the largest share in the global veterinary infectious disease diagnostics market in the forecasted period
North America accounted for the largest share of the global veterinary infectious disease diagnostics market during the forecast period. The growth in the veterinary infectious disease diagnostics market of North America is characterized by the increasing population of companion and food-producing animals, rising meat and dairy product consumption, the availability of technologically advanced veterinary reference laboratories, rising veterinary healthcare expenditure, and growth in pet insurance coverage.

The break of primary participants was as mentioned below:
•By Company Type – Tier 1–60%, Tier 2–30%, and Tier 3–10%
•By Designation – C-level–30%, Director-level–50%, Others–20%
•By Region – North America–45%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East and Africa–5%

Key players in the veterinary infectious disease diagnostics market

The key players in the veterinary diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), Thermo Fisher Scientific, Inc. (US), Virbac (France), bioMérieux SA (France), Heska Corporation (US), IDvet (France), NEOGEN Corporation (US), QIAGEN N.V. (a part of INDICAL Bioscience) (Europe), Randox Laboratories Ltd. (UK), Agrolabo S.p.A. (Italy), Bio-Rad Laboratories (US), Bionote, Inc. (South Korea), Biogal Galed Labs (Israel), BioChek (Netherlands), (UK), Biopanda Reagents (UK), URIT Medical Electronic Co. Ltd. (China), MEGACOR Diagnostik GmbH (Austria), LIVET (UK), INDICAL BIOSCIENCE GmbH (Germany), Fassisi GmbH (Germany), Alvedia (France), SKYER, Inc. (South Korea), Shenzhen Bioeasy Biotechnology Co., Ltd. (China), and Precision Biosensor (US).
Research Coverage:
The report analyzes the veterinary infectious disease diagnostics market and aims at estimating the market size and future growth potential of this market based on various segments such as technology, animal type, end user, and region. The report also includes a product portfolio matrix of various veterinary infectious disease diagnostics products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.
Reasons to Buy the Report
The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.
This report provides insights into the following pointers:
•Market Penetration: Comprehensive information on product portfolios offered by the top players in the global veterinary infectious disease diagnostics market. The report analyzes this market by technology, animal type, and end user.
•Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global veterinary infectious disease diagnostics market.
•Market Development: Comprehensive information on the lucrative emerging markets by technology, animal type, and end user.
•Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global veterinary infectious disease diagnostics market.
•Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global veterinary infectious disease diagnostics market.

目次

1INTRODUCTION41
1.1OBJECTIVES OF THE STUDY41
1.2MARKET DEFINITION & SCOPE41
1.2.1INCLUSIONS & EXCLUSIONS41
1.2.2MARKET SEGMENTATION42
FIGURE 1VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SEGMENTATION42
1.2.3YEARS CONSIDERED FOR THE STUDY43
1.3CURRENCY43
TABLE 1EXCHANGE RATES UTILIZED FOR CONVERSION TO USD43
1.4STAKEHOLDERS44
1.5SUMMARY OF CHANGES44
2RESEARCH METHODOLOGY46
2.1RESEARCH DATA46
FIGURE 2RESEARCH DESIGN46
2.1.1SECONDARY DATA47
2.1.1.1Key data from secondary sources48
2.1.2PRIMARY DATA48
FIGURE 3PRIMARY SOURCES48
2.1.2.1Key data from primary sources49
2.1.2.2Insights from primary experts50
2.1.2.3Key industry insights50
FIGURE 4BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS50
FIGURE 5BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE PARTICIPANTS,
BY COMPANY TYPE, DESIGNATION, AND REGION51
FIGURE 6BREAKDOWN OF PRIMARY INTERVIEWS: DEMAND-SIDE PARTICIPANTS,
BY END USER, DESIGNATION, AND REGION51
2.2MARKET SIZE ESTIMATION52
FIGURE 7SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS52
FIGURE 8REVENUE SHARE ANALYSIS ILLUSTRATION: IDEXX LABORATORIES, INC.53
FIGURE 9SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: COMPANION DIAGNOSTICS MARKET (2020)53
FIGURE 10SUPPLY-SIDE ANALYSIS OF THE TOP COMPANIES: FOOD-PRODUCING ANIMALS DIAGNOSTICS MARKET (2020)54
FIGURE 11CAGR PROJECTIONS FROM THE ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2021–2026)55
FIGURE 12CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS56
FIGURE 13TOP-DOWN APPROACH56
 
2.3MARKET BREAKDOWN & DATA TRIANGULATION57
FIGURE 14MARKET DATA TRIANGULATION METHODOLOGY57
2.4MARKET SHARE ANALYSIS58
2.5ASSUMPTIONS FOR THE STUDY58
2.6LIMITATIONS58
2.7RISK ASSESSMENT59
TABLE 2RISK ASSESSMENT: VETERINARY INFECTIOUS DISEASE
DIAGNOSTICS MARKET59
3EXECUTIVE SUMMARY60
FIGURE 15VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD MILLION)60
FIGURE 16VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2021 VS. 2026 (USD MILLION)61
FIGURE 17VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)61
FIGURE 18GEOGRAPHICAL SNAPSHOT OF THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET62
4PREMIUM INSIGHTS64
4.1VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET OVERVIEW64
FIGURE 19GROWING PREVALENCE OF ZOONOTIC DISEASES TO DRIVE
THE MARKET GROWTH64
4.2ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER AND COUNTRY (2020)65
FIGURE 20THE VETERINARY REFERENCE LABORATORIES SEGMENT ACCOUNTED FOR THE LARGEST SHARE OF THE APAC MARKET IN 202065
4.3VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES66
FIGURE 21ASIA PACIFIC TO REGISTER THE HIGHEST GROWTH IN THE GLOBAL MARKET DURING THE FORECAST PERIOD66
4.4VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION (2019–2026)67
FIGURE 22NORTH AMERICA WILL CONTINUE TO DOMINATE THE MARKET DURING THE FORECAST PERIOD67
4.5VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEVELOPED VS. DEVELOPING MARKETS67
FIGURE 23DEVELOPING MARKETS TO REGISTER A HIGHER GROWTH RATE DURING THE FORECAST PERIOD67
5MARKET OVERVIEW68
5.1INTRODUCTION68
5.2MARKET DYNAMICS68
FIGURE 24VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES68
5.2.1MARKET DRIVERS69
5.2.1.1Rising demand for animal-derived food products69
TABLE 3PAST AND PROJECTED TRENDS IN THE CONSUMPTION OF MEAT & MILK IN DEVELOPED AND DEVELOPING COUNTRIES69
TABLE 4ASIA: COUNTRY-LEVEL CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2020 VS. 2030 (THOUSAND METRIC TONS)70
FIGURE 25ASIA WAS THE HIGHEST CONSUMER OF MEAT AND MILK IN 201870
5.2.1.2Increasing companion animal population71
5.2.1.3Rising demand for pet insurance and the subsequent growth in animal health expenditure71
TABLE 5AVERAGE PREMIUMS PAID IN THE US, 2019 VS. 202072
FIGURE 26US: PET INDUSTRY EXPENDITURE, 2010–201972
5.2.1.4Growing number of veterinary practitioners in developed economies73
TABLE 6NUMBER OF VETERINARIANS AND PARAVETERINARIANS IN DEVELOPED COUNTRIES, 2012–201873
5.2.1.5Increasing disease control & disease prevention measures73
5.2.1.6Rising incidence of transboundary & zoonotic diseases74
TABLE 7ANIMAL DISEASE OUTBREAKS IN ASIA PACIFIC COUNTRIES (2009–2019)74
5.2.1.7Growing demand for advanced diagnostic devices75
5.2.2MARKET RESTRAINTS76
5.2.2.1Rising pet care costs76
5.2.2.2High costs of veterinary diagnostic tests77
5.2.3MARKET OPPORTUNITIES77
5.2.3.1Increasing use of PCR-testing panels for COVID-19 testing in animals77
5.2.3.2Untapped emerging economies78
5.2.4MARKET CHALLENGES78
5.2.4.1Shortage of veterinary practitioners in developing markets78
5.2.4.2Lack of animal healthcare awareness in emerging countries79
TABLE 8NUMBER OF VETERINARY PROFESSIONALS, BY COUNTRY,
2005 VS. 2014 VS. 201879
5.3IMPACT OF COVID-19 ON THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET80
TABLE 9GLOBAL SNAPSHOT OF THE REPORTED CASES OF NATURALLY ACQUIRED SARS- COV-2 (COVID-19) INFECTIONS IN ANIMALS80
FIGURE 27MONTHLY VETERINARY PRACTICE ACTIVITY, BY REGION,
JANUARY–JUNE 202081
5.4INDUSTRY TRENDS81
5.4.1RISING VEGAN POPULATION81
5.4.2ADOPTION OF WEB MONITORING AND OTHER DIGITAL AIDS TO DETECT EMERGING INFECTIOUS DISEASES IN ANIMALS82
5.4.3EXPANSIVE GROWTH IN VETERINARY BUSINESSES82
5.5VALUE CHAIN ANALYSIS83
FIGURE 28VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: VALUE CHAIN ANALYSIS83
5.6ECOSYSTEM MARKET MAP83
FIGURE 29VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: ECOSYSTEM PARTICIPANTS84
FIGURE 30VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET:
ECOSYSTEM MARKET84
5.7PORTER’S FIVE FORCES ANALYSIS85
TABLE 10VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: PORTER’S FIVE FORCES ANALYSIS85
5.7.1THREAT OF NEW ENTRANTS85
5.7.2THREAT OF SUBSTITUTES86
5.7.3BARGAINING POWER OF SUPPLIERS86
5.7.4BARGAINING POWER OF BUYERS86
5.7.5INTENSITY OF COMPETITIVE RIVALRY86
5.8PRICING ANALYSIS87
TABLE 11REGIONAL PRICING ANALYSIS OF VETERINARY ANALYZERS, 2021 (USD)87
5.9PATENT ANALYSIS87
5.9.1PATENT PUBLICATION TRENDS FOR VETERINARY DIAGNOSTICS88
5.9.2PATENT PUBLICATION TRENDS (2011–DECEMBER 2021)88
5.9.3INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS88
FIGURE 31TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTIC PATENTS (JANUARY
2011–DECEMBER 2021)89
FIGURE 32TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PATENTS (JANUARY 2011–DECEMBER 2021)90
5.10TECHNOLOGICAL ANALYSIS90
5.10.1KEY TECHNOLOGY90
5.10.1.1Development of portable instruments for POC diagnostic services90
TABLE 12PONT-OF-CARE PORTABLE VETERINARY DIAGNOSTIC INSTRUMENTS90
5.10.2ADJACENT TECHNOLOGY91
5.10.2.1Development of rapid and sensitive veterinary diagnostic kits91
6VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY92
6.1INTRODUCTION93
TABLE 13VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)93
6.2IMMUNODIAGNOSTICS93
TABLE 14KEY VETERINARY IMMUNODIAGNOSTIC PRODUCTS AVAILABLE IN THE MARKET94
TABLE 15VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)95
TABLE 16VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR IMMUNODIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)95
6.2.1LATERAL FLOW ASSAYS96
6.2.1.1Lateral flow assays offer rapid results & accurate diagnosis96
TABLE 17LATERAL FLOW ASSAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)97
6.2.2ELISA TESTS97
6.2.2.1ELISA tests have gained widespread popularity in the market owing to their efficacy and accurate validation of results97
TABLE 18ELISA TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)98
6.2.3OTHER IMMUNODIAGNOSTIC PRODUCTS98
TABLE 19OTHER IMMUNODIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)99
6.3MOLECULAR DIAGNOSTICS99
TABLE 20KEY VETERINARY MOLECULAR DIAGNOSTICS PRODUCTS
AVAILABLE IN THE MARKET100
TABLE 21VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY TYPE, 2019–2026 (USD MILLION)101
TABLE 22VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR MOLECULAR DIAGNOSTICS, BY COUNTRY, 2019–2026 (USD MILLION)101
6.3.1POLYMERASE CHAIN REACTION (PCR) TESTS102
6.3.1.1PCR is an effective tool for the diagnosis of diseases in food-producing animals and companion animals102
TABLE 23PCR TESTS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)102
6.3.2MICROARRAYS103
6.3.2.1Technological advancements and the increasing incidence of infectious diseases are factors supporting the growth of this market103
TABLE 24MICROARRAYS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)103
6.3.3OTHER MOLECULAR DIAGNOSTIC PRODUCTS104
TABLE 25OTHER MOLECULAR DIAGNOSTIC PRODUCTS MARKET, BY COUNTRY,
2019–2026 (USD MILLION)104
6.4OTHER TECHNOLOGIES105
TABLE 26VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2019–2026 (USD MILLION)105
7VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE106
7.1INTRODUCTION107
TABLE 27VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)107
7.2COMPANION ANIMALS107
TABLE 28POPULATION OF COMPANION ANIMALS, BY COUNTRY,
2012–2019 (MILLION)108
TABLE 29INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)108
TABLE 30INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY COUNTRY, 2019–2026 (USD MILLION)109
7.2.1DOGS109
7.2.1.1The pet dog population has grown significantly in recent years109
TABLE 31SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING DOGS110
TABLE 32SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING DOGS110
TABLE 33VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR DOGS,
BY COUNTRY, 2019–2026 (USD MILLION)114
7.2.2CATS115
7.2.2.1Increasing pet cat population to drive the market growth115
TABLE 34SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATS115
TABLE 35SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATS115
TABLE 36VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATS,
BY COUNTRY, 2019–2026 (USD MILLION)119
7.2.3HORSES119
7.2.3.1Research programs on horse health awareness is a major factor driving the demand for infection diagnostics for this segment119
TABLE 37HORSE POPULATION, BY REGION, 2014–2017 (USD MILLION)120
TABLE 38SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING HORSES120
TABLE 39SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING HORSES121
TABLE 40VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR HORSES,
BY COUNTRY, 2019–2026 (USD MILLION)124
7.2.4OTHER COMPANION ANIMALS124
TABLE 41VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER COMPANION ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)125
7.2.5INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY INFECTION TYPE125
TABLE 42INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY INFECTION TYPE, 2019–2026 (USD MILLION)126
7.2.5.1Viral infections126
7.2.5.1.1The highly contagious nature of viral diseases is a major factor driving the demand for infection diagnostics in companion animals126
TABLE 43PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN COMPANION ANIMALS127
TABLE 44VIRAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION)128
7.2.5.2Bacterial infections128
7.2.5.2.1The bacterial infections segment accounted for the largest share of the market in 2020128
TABLE 45PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN COMPANION ANIMALS129
TABLE 46BACTERIAL DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION)130
7.2.5.3Parasitic infections130
7.2.5.3.1Rising incidence of worm infestation in companion animals to support the growth of this market130
TABLE 47PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS IN COMPANION ANIMALS131
TABLE 48PARASITIC DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS,
BY REGION, 2019–2026 (USD MILLION)132
7.2.5.4Other infections132
TABLE 49PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN COMPANION ANIMALS133
TABLE 50PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS IN COMPANION ANIMALS133
TABLE 51OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY REGION, 2019–2026 (USD MILLION)133
 
7.3FOOD-PRODUCING ANIMALS134
7.3.1INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE134
TABLE 52POPULATION OF FOOD-PRODUCING ANIMALS IN THE US,
2012 TO 2019 (MILLION)134
TABLE 53INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY ANIMAL TYPE, 2019–2026 (USD MILLION)134
TABLE 54INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)135
7.3.1.1Cattle135
7.3.1.1.1Growing demand for meat & dairy products to support the growth of this segment135
TABLE 55SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING CATTLE136
TABLE 56SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING CATTLE136
TABLE 57VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR CATTLE,
BY COUNTRY, 2019–2026 (USD MILLION)139
7.3.1.2Swine139
7.3.1.2.1Extensive use of infectious disease diagnostics as a response to epidemic outbreaks in this segment139
TABLE 58SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING SWINE140
TABLE 59SOME OF THE MAJOR INFECTIOUS DISEASES AFFECTING SWINE140
TABLE 60VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR SWINE,
BY COUNTRY, 2019–2026 (USD MILLION)144
7.3.1.3Poultry144
7.3.1.3.1The growth of this segment is driven by the growing poultry population and rising production volumes144
TABLE 61SOME OF THE IMPORTANT ZOONOTIC DISEASES AFFECTING POULTRY145
TABLE 62SOME IMPORTANT INFECTIOUS DISEASES AFFECTING POULTRY145
TABLE 63VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POULTRY,
BY COUNTRY, 2019–2026 (USD MILLION)148
7.3.1.4Other food-producing animals148
TABLE 64SOME OF THE MAJOR ZOONOTIC DISEASES AFFECTING OTHER FOOD -PRODUCING ANIMALS149
TABLE 65VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR OTHER FOOD-PRODUCING ANIMALS, BY COUNTRY, 2019–2026 (USD MILLION)150
7.3.2VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE150
TABLE 66VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)151
7.3.2.1Bacterial infections151
7.3.2.1.1The bacterial infections segment accounted for the largest share of the food-producing animals market in 2020151
TABLE 67PRODUCTS OFFERED FOR THE DIAGNOSIS OF BACTERIAL INFECTIONS IN FOOD-PRODUCING ANIMALS152
TABLE 68BACTERIAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)153
7.3.2.2Viral infections153
7.3.2.2.1Need for early disease diagnosis and the rising awareness for viral infections to support the market growth153
TABLE 69PRODUCTS OFFERED FOR THE DIAGNOSIS OF VIRAL INFECTIONS IN FOOD-PRODUCING ANIMALS154
TABLE 70VIRAL DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS,
BY REGION, 2019–2026 (USD MILLION)155
7.3.2.3Parasitic infections156
7.3.2.3.1Worm infestations are a significant problem for pet & companion animal owners156
TABLE 71PRODUCTS OFFERED FOR THE DIAGNOSIS OF PARASITIC INFECTIONS
IN FOOD-PRODUCING ANIMALS156
TABLE 72PARASITIC DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)157
7.3.2.4Other infections157
TABLE 73PRODUCTS OFFERED FOR THE DIAGNOSIS OF FUNGAL INFECTIONS IN FOOD-PRODUCING ANIMALS158
TABLE 74PRODUCTS OFFERED FOR THE DIAGNOSIS OF OTHER INFECTIONS
IN FOOD- PRODUCING ANIMALS158
TABLE 75OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY REGION, 2019–2026 (USD MILLION)159
8VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY END USER160
8.1INTRODUCTION161
TABLE 76VETERINARY INFECTIOUS DISEASES DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)161
8.2VETERINARY REFERENCE LABORATORIES161
8.2.1VETERINARY REFERENCE LABORATORIES IS THE LARGEST
END USER SEGMENT161
TABLE 77VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2019–2026 (USD MILLION)162
8.3VETERINARY HOSPITALS & CLINICS163
8.3.1INCREASED PET OWNERSHIP AND SPENDING ON PET CARE TO PROPEL MARKET GROWTH163
FIGURE 33US: PET INDUSTRY EXPENDITURE163
FIGURE 34ANNUAL ROUTINE VETERINARY VISIT EXPENDITURE: DOGS AND CATS164
TABLE 78VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR VETERINARY HOSPITALS & CLINICS, BY COUNTRY, 2019–2026 (USD MILLION)165
8.4POINT-OF-CARE/ IN-HOUSE TESTING165
8.4.1POINT-OF-CARE TESTING IS EASY-TO-USE, COST-EFFECTIVE, AND OFFERS SWIFT RESULTS165
TABLE 79KEY PRODUCTS OFFERED BY MARKET PLAYERS166
TABLE 80VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR POINT-OF-CARE/ IN-HOUSE TESTING, BY COUNTRY, 2019–2026 (USD MILLION)167
8.5VETERINARY RESEARCH INSTITUTES & UNIVERSITIES167
8.5.1INCREASING COLLABORATIONS BETWEEN PRIVATE COMPANIES AND VETERINARY RESEARCH INSTITUTES & UNIVERSITIES TO DRIVE MARKET GROWTH167
TABLE 81VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
VETERINARY RESEARCH INSTITUTES & UNIVERSITIES, BY COUNTRY,
2019–2026 (USD MILLION)169
9VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION170
9.1INTRODUCTION171
TABLE 82VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION, 2019–2026 (USD MILLION)171
9.2NORTH AMERICA172
FIGURE 35EXPECTED GROWTH IN THE NUMBER OF VETERINARIANS IN NORTH AMERICA173
FIGURE 36NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT173
TABLE 83NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)174
TABLE 84NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)174
TABLE 85NORTH AMERICA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)174
TABLE 86NORTH AMERICA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)175
TABLE 87NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)175
TABLE 88NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)175
TABLE 89NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)176
TABLE 90NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)176
TABLE 91NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)176
TABLE 92NORTH AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)177
9.2.1US177
9.2.1.1The US dominated the North American veterinary infectious disease diagnostics market in 2020177
FIGURE 37US: DOGS POPULATION, 2012–2020 (MILLION)177
FIGURE 38US: EXPENDITURE ON VET VISITS178
TABLE 93US: FOOD-PRODUCING ANIMAL POPULATION, 2001–2019 (MILLION)178
FIGURE 39US: NUMBER OF CATS AND DOGS TESTED POSITIVE FOR COVID-19 (2020)179
TABLE 94US: NUMBER OF VETERINARIANS IN PRIVATE CLINICAL PRACTICES,
2014–2019179
TABLE 95US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)180
TABLE 96US: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)180
TABLE 97US: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)180
TABLE 98US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)181
TABLE 99US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)181
TABLE 100US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)181
TABLE 101US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)182
TABLE 102US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)182
TABLE 103US: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)182
9.2.2CANADA183
9.2.2.1Growing pet adoption in Canada to drive the market growth183
FIGURE 40CANADA: COMPANION ANIMAL POPULATION, 2016–2020 (MILLION)183
TABLE 104CANADA: LARGE ANIMAL POPULATION, 2001–2019 (MILLION)183
TABLE 105CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)184
TABLE 106CANADA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)184
TABLE 107CANADA: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)184
TABLE 108CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)185
TABLE 109CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)185
TABLE 110CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)185
TABLE 111CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)186
TABLE 112CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)186
TABLE 113CANADA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)186
9.3EUROPE187
TABLE 114EUROPE: COMPANION POPULATION, 2019 (MILLION)187
TABLE 115EUROPE: LIVESTOCK POPULATION, 2019 (MILLION)187
FIGURE 41EU-27: LIVESTOCK POPULATION, 2012-2019 (MILLION)188
TABLE 116EUROPE: NUMBER OF VETERINARIANS, 2012–2019189
TABLE 117EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)189
TABLE 118EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)189
TABLE 119EUROPE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)190
TABLE 120EUROPE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)190
TABLE 121EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)190
TABLE 122EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)191
TABLE 123EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)191
TABLE 124EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)191
TABLE 125EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION)192
TABLE 126EUROPE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)192
9.3.1GERMANY192
9.3.1.1Rising awareness regarding zoonotic diseases to drive the market growth in Germany192
TABLE 127GERMANY: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)193
TABLE 128GERMANY: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)193
TABLE 129GERMANY: NUMBER OF VETERINARIANS, 2014 VS. 2019194
TABLE 130GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)194
TABLE 131GERMANY: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)194
TABLE 132GERMANY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)195
TABLE 133GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)195
TABLE 134GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)195
TABLE 135GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)196
TABLE 136GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)196
TABLE 137GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS
MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION)196
TABLE 138GERMANY: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY END USER, 2019–2026 (USD MILLION)197
9.3.2UK197
9.3.2.1The UK is the fastest-growing market for veterinary infectious disease diagnostics in Europe197
TABLE 139UK: COMPANION ANIMAL POPULATION (2010–2019) (MILLION)197
TABLE 140UK: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)198
TABLE 141UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)198
TABLE 142UK: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)199
TABLE 143UK: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)199
TABLE 144UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)199
TABLE 145UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)200
TABLE 146UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)200
TABLE 147UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)200
TABLE 148UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)201
TABLE 149UK: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)201
9.3.3FRANCE201
9.3.3.1France is one of the leading markets for companion pet ownership201
TABLE 150FRANCE: COMPANION ANIMAL POPULATION, 2010–2019 (MILLION)202
TABLE 151FRANCE: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)202
TABLE 152FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)203
TABLE 153FRANCE: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)203
TABLE 154FRANCE: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)203
TABLE 155FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)204
TABLE 156FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)204
TABLE 157FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)204
TABLE 158FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)205
TABLE 159FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE,
2019–2026 (USD MILLION)205
TABLE 160FRANCE: VETERINARY INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY END USER, 2019–2026 (USD MILLION)205
9.3.4ITALY206
9.3.4.1Rising awareness about pet healthcare to propel the market growth for veterinary diagnostic products in Italy206
TABLE 161ITALY: COMPANION ANIMAL POPULATION, 2012–2019 (MILLION)206
TABLE 162ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)207
TABLE 163ITALY: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)207
TABLE 164ITALY: VETERINARY INFECTIOUS DISEASE MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)207
TABLE 165ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)208
TABLE 166ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)208
TABLE 167ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)208
TABLE 168ITALY: VETERINARY DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)209
TABLE 169ITALY: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)209
TABLE 170ITALY: VETERINARY DIAGNOSTICS MARKET, BY END USER,
2019–2026 (USD MILLION)209
9.3.5SPAIN210
9.3.5.1Growing demand for pig & poultry products to support the adoption of veterinary diagnostic products in Spain210
TABLE 171SPAIN: COMPANION ANIMAL POPULATION, 2016–2019 (MILLION)210
TABLE 172SPAIN: LIVESTOCK ANIMAL POPULATION, 2016–2019 (MILLION)211
TABLE 173SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)211
TABLE 174SPAIN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)211
TABLE 175SPAIN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)212
TABLE 176SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)212
TABLE 177SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)212
TABLE 178SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)213
TABLE 179SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)213
TABLE 180SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)213
TABLE 181SPAIN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)214
9.3.6REST OF EUROPE214
TABLE 182ROE: COMPANION ANIMAL OWNERSHIP, BY COUNTRY, 2019 (MILLION)214
TABLE 183ROE: LIVESTOCK ANIMAL POPULATION, BY COUNTRY, 2019 (MILLION)215
TABLE 184ROE: NUMBER OF VETERINARIANS AND PARAVETERINARIANS,
2010 VS. 2019215
TABLE 185ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)215
TABLE 186ROE: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)216
TABLE 187ROE: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)216
TABLE 188ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)216
TABLE 189ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)217
TABLE 190ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)217
TABLE 191ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)217
TABLE 192ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)218
TABLE 193ROE: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)218
9.4ASIA PACIFIC218
FIGURE 42ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SNAPSHOT219
TABLE 194ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY COUNTRY, 2019–2026 (USD MILLION)220
TABLE 195ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)220
TABLE 196ASIA PACIFIC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)220
TABLE 197ASIA PACIFIC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)221
TABLE 198ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)221
TABLE 199ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)221
TABLE 200ASIA PACIFIC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)222
TABLE 201ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)222
TABLE 202ASIA PACIFIC: FOOD-PRODUCING ANIMALS ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)222
TABLE 203ASIA PACIFIC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)223
9.4.1CHINA223
9.4.1.1China dominated the APAC veterinary infectious disease diagnostic market in 2020223
TABLE 204CHINA: LIVESTOCK POPULATION, 2010-2019 (MILLION)224
TABLE 205CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)224
TABLE 206CHINA: VETERINARY INFECTIOUS DISEASE IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)225
TABLE 207CHINA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)225
TABLE 208CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)225
TABLE 209CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)226
TABLE 210CHINA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION)226
TABLE 211CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)226
TABLE 212CHINA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)227
TABLE 213CHINA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)227
9.4.2JAPAN227
9.4.2.1Rising awareness about zoonotic diseases and increasing pet expenditure to drive market growth227
TABLE 214JAPAN: PRODUCTION, CONSUMPTION, IMPORT, AND EXPORT OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)228
TABLE 215JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)228
TABLE 216JAPAN: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)229
TABLE 217JAPAN: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)229
TABLE 218JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)229
TABLE 219JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)230
TABLE 220JAPAN: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION)230
TABLE 221JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)230
TABLE 222JAPAN: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)231
TABLE 223JAPAN: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)231
9.4.3INDIA231
9.4.3.1India to become an untapped market with huge growth potential231
TABLE 224INDIA: LIVESTOCK POPULATION, 2007-2019 (MILLION)232
TABLE 225INDIA: PRODUCTION AND CONSUMPTION OF ANIMAL-DERIVED FOOD PRODUCTS, 2000 VS. 2030 (THOUSAND METRIC TONS)232
TABLE 226INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)233
TABLE 227INDIA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)233
TABLE 228INDIA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)233
TABLE 229INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)234
TABLE 230INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)234
TABLE 231INDIA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION)234
TABLE 232INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)235
TABLE 233INDIA: FOOD- PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)235
TABLE 234INDIA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)236
9.4.4REST OF APAC236
TABLE 235REST OF APAC: LIVESTOCK POPULATION, BY COUNTRY,
2010-2019 (MILLION)237
TABLE 236ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)238
TABLE 237ROAPAC: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)238
TABLE 238ROAPAC: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)238
TABLE 239ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)239
TABLE 240ROAPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)239
TABLE 241ROAPAC: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)239
TABLE 242ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)240
TABLE 243ROPAC: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)240
TABLE 244ROPAC: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)241
9.5LATIN AMERICA241
TABLE 245LATIN AMERICA: LIVESTOCK POPULATION, BY COUNTRY,
2010-2019 (MILLION)242
TABLE 246LATIN AMERICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS, 2010 VS. 2019242
TABLE 247LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)242
TABLE 248LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY TECHNOLOGY, 2019–2026 (USD MILLION)243
TABLE 249LATIN AMERICA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)243
TABLE 250LATIN AMERICA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT, 2019–2026 (USD MILLION)243
TABLE 251LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY ANIMAL TYPE, 2019–2026 (USD MILLION)244
TABLE 252LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)244
TABLE 253LATIN AMERICA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)244
TABLE 254LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)245
TABLE 255LATIN AMERICA: FOOD-PRODUICNG ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)245
TABLE 256LATIN AMERICA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)246
9.5.1BRAZIL246
9.5.1.1Brazil has the fourth-largest pet population in the world246
TABLE 257BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)247
TABLE 258BRAZIL: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)247
TABLE 259BRAZIL: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)247
TABLE 260BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)248
TABLE 261BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)248
TABLE 262BRAZIL: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)248
TABLE 263BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)249
TABLE 264BRAZIL: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)249
TABLE 265BRAZIL: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)249
9.5.2MEXICO250
9.5.2.1Mexico is the second-largest pet care market in Latin America250
TABLE 266MEXICO: INCREASE IN LIVESTOCK POPULATION, 2010–2019 (MILLION)250
TABLE 267MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)250
TABLE 268MEXICO: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)251
TABLE 269MEXICO: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)251
TABLE 270MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)251
TABLE 271MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)252
TABLE 272MEXICO: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)252
TABLE 273MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)252
TABLE 274MEXICO: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)253
TABLE 275MEXICO: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY END USER, 2019–2026 (USD MILLION)253
9.5.3REST OF LATIN AMERICA253
TABLE 276ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)254
TABLE 277ROLA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)254
TABLE 278ROLA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)254
TABLE 279ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)255
TABLE 280ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)255
TABLE 281ROLA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION)255
TABLE 282ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)256
TABLE 283ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR FOOD-PRODUCING ANIMALS, BY INFECTION TYPE, 2019–2026 (USD MILLION)256
TABLE 284ROLA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)256
9.6MIDDLE EAST & AFRICA257
9.6.1MIDDLE EAST & AFRICA IS AN EMERGING MARKET FOR VETERINARY INFECTIOUS DISEASE DIAGNOSTICS PRODUCTS257
TABLE 285MIDDLE EAST: LIVESTOCK POPULATION, 2010 VS. 2019 (MILLION)257
TABLE 286MIDDLE EAST: NUMBER OF VETERINARIANS AND PARAVETERINARIANS, 2010 VS. 2018257
TABLE 287AFRICA: FOOD-PRODUCING ANIMAL POPULATION, 2012–2019 (MILLION)258
TABLE 288AFRICA: NUMBER OF VETERINARIANS AND PARA VETERINARIANS,
2010–2018258
TABLE 289MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY TECHNOLOGY, 2019–2026 (USD MILLION)258
TABLE 290MEA: VETERINARY INFECTIOUS IMMUNODIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)259
TABLE 291MEA: VETERINARY INFECTIOUS MOLECULAR DIAGNOSTICS MARKET,
BY PRODUCT, 2019–2026 (USD MILLION)259
TABLE 292MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY ANIMAL TYPE, 2019–2026 (USD MILLION)259
TABLE 293MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR COMPANION ANIMALS, BY TYPE, 2019–2026 (USD MILLION)260
TABLE 294MEA: COMPANION ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET,
BY INFECTION TYPE, 2019–2026 (USD MILLION)260
TABLE 295MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET FOR
FOOD-PRODUCING ANIMALS, BY TYPE, 2019–2026 (USD MILLION)260
TABLE 296MEA: FOOD-PRODUCING ANIMAL INFECTIOUS DISEASE DIAGNOSTIC MARKET, BY INFECTION TYPE, 2019–2026 (USD MILLION)261
TABLE 297MEA: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET,
BY END USER, 2019–2026 (USD MILLION)261
10COMPETITIVE LANDSCAPE262
10.1OVERVIEW262
10.2KEY PLAYER STRATEGIES/ RIGHT TO WIN262
10.2.1OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET263
10.3REVENUE SHARE ANALYSIS OF THE TOP MARKET PLAYERS264
FIGURE 43REVENUE ANALYSIS OF THE TOP PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET265
10.4MARKET SHARE ANALYSIS265
FIGURE 44VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET SHARE,
BY KEY PLAYER, 2020266
TABLE 298VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: DEGREE
OF COMPETITION266
10.5COMPETITIVE LEADERSHIP MAPPING268
10.5.1STARS268
10.5.2EMERGING LEADERS268
10.5.3PERVASIVE PLAYERS268
10.5.4PARTICIPANTS268
FIGURE 45VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING (2020)269
10.6COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS270
10.6.1PROGRESSIVE COMPANIES270
10.6.2DYNAMIC COMPANIES270
10.6.3STARTING BLOCKS270
10.6.4RESPONSIVE COMPANIES270
FIGURE 46VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR STARTUPS (2020)271
10.7COMPANY FOOTPRINT272
TABLE 299COMPANY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET272
10.7.1TECHNOLOGY FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET273
TABLE 300TECHNOLOGY FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)273
10.7.2ANIMAL FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET274
TABLE 301ANIMAL TYPE FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)274
10.7.3END-USER FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET275
TABLE 302END-USER FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)275
10.7.4GEOGRAPHIC FOOTPRINT OF MAJOR PLAYERS IN THE VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET276
TABLE 303GEOGRAPHIC FOOTPRINT: VETERINARY INFECTIOUS DISEASE DIAGNOSTICS MARKET (2020)276
10.8COMPETITIVE SCENARIO277
10.8.1PRODUCT LAUNCHES277
TABLE 304PRODUCT LAUNCHES, 2018–2021277
10.8.2DEALS277
TABLE 305DEALS, 2018–2021277
10.8.3OTHER DEVELOPMENTS278
TABLE 306OTHER DEVELOPMENTS, 2018–2021278
 
11COMPANY PROFILES279
11.1KEY PLAYERS279
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1IDEXX LABORATORIES, INC.279
TABLE 307IDEXX LABORATORIES, INC.: BUSINESS OVERVIEW279
FIGURE 47IDEXX LABORATORIES, INC.: COMPANY SNAPSHOT (2020)280
11.1.2ZEOTIS290
TABLE 308ZOETIS: BUSINESS OVERVIEW290
FIGURE 48ZOETIS: COMPANY SNAPSHOT (2020)291
11.1.3THERMO FISHER SCIENTIFIC INC.296
TABLE 309THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW296
FIGURE 49THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020)297
11.1.4VIRBAC307
TABLE 310VIRBAC: BUSINESS OVERVIEW307
FIGURE 50VIRBAC: COMPANY SNAPSHOT (2020)308
11.1.5BIOMERIEUX S.A.310
TABLE 311BIOMERIEUX S.A.: BUSINESS OVERVIEW310
FIGURE 51BIOMERIEUX S.A.: COMPANY SNAPSHOT (2020)311
11.1.6HESKA CORPORATION316
TABLE 312HESKA CORPORATION: BUSINESS OVERVIEW316
FIGURE 52HESKA CORPORATION: COMPANY SNAPSHOT (2020)317
11.1.7IDVET320
TABLE 313IDVET: BUSINESS OVERVIEW320
11.1.8NEOGEN CORPORATION328
TABLE 314NEOGEN CORPORATION: BUSINESS OVERVIEW328
FIGURE 53NEOGEN CORPORATION: COMPANY SNAPSHOT (2020)329
11.1.9QIAGEN N.V. (A PART OF INDICAL BIOSCIENCE)335
TABLE 315QIAGEN N.V.: BUSINESS OVERVIEW335
FIGURE 54QIAGEN N.V.: COMPANY SNAPSHOT (2020)336
11.1.10RANDOX LABORATORIES LTD.339
TABLE 316RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW339
11.1.11AGROLABO S.P.A.341
TABLE 317AGROLABO S.P.A.: BUSINESS OVERVIEW341
11.1.12BIONOTE USA INC.352
TABLE 318BIONOTE USA INC.: BUSINESS OVERVIEW352
11.1.13BIOGAL GALED LABS355
TABLE 319BIOGAL GALED LABS: BUSINESS OVERVIEW355
11.1.14BIOCHEK357
TABLE 320BIOCHEK: BUSINESS OVERVIEW357
11.1.15BIOPANDA REAGENTS LTD.362
TABLE 321BIOPANDA REAGENTS LTD.: BUSINESS OVERVIEW362
11.1.16URIT MEDICAL ELECTRONIC CO., LTD.364
TABLE 322URIT MEDICAL ELECTRONIC CO., LTD.: BUSINESS OVERVIEW364
11.1.17MEGACOR DIAGNOSTIK GMBH366
TABLE 323MEGACOR DIAGNOSTIK GMBH: BUSINESS OVERVIEW366
11.1.18BIO-RAD LABORATORIES, INC.369
TABLE 324BIO-RAD LABORATORIES: BUSINESS OVERVIEW369
FIGURE 55BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2020)370
11.1.19LIVET372
TABLE 325LIVET: BUSINESS OVERVIEW372
11.1.20INDICAL BIOSCIENCE GMBH373
TABLE 326INDICAL BIOSCIENCE GMBH: BUSINESS OVERVIEW373
11.2OTHER PLAYERS376
11.2.1FASSISI, GMBH376
11.2.2ALVEDIA377
11.2.3SKYER, INC.378
11.2.4SHENZHEN BIOEASY BIOTECHNOLOGY CO., LTD.379
11.2.5PRECISION BIOSENSOR381
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12APPENDIX382
12.1INSIGHTS FROM INDUSTRY EXPERTS382
12.2DISCUSSION GUIDE383
12.3KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL389
12.4AVAILABLE CUSTOMIZATIONS391
12.5RELATED REPORTS391
12.6AUTHOR DETAILS392